NFG
AZN icon

Next Financial Group’s AstraZeneca AZN Stock Holding History

Next Financial Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$109K Buy
932
+442
+90% +$52K 0.01% 1118
2021
Q3 		$59K Buy
490
+341
+229% +$39.7K ﹤0.01% 1342
2021
Q2 		$18K Sell
149
-496
-77% -$54.4K ﹤0.01% 1782
2021
Q1 		$65K Buy
645
+202
+46% +$20.3K 0.01% 1178
2020
Q4 		$44K Buy
443
+355
+403% +$37.6K ﹤0.01% 1234
2020
Q3 		$10K Buy
+88
New +$9.79K ﹤0.01% 1616
2020
Q2 		– Sell
-51
Closed -$5K – 697
2020
Q1 		$5K Sell
51
-1,514
-97% -$143K ﹤0.01% 1689
2019
Q4 		$156K Sell
1,565
-1,157
-43% -$109K 0.02% 777
2019
Q3 		$243K Sell
2,722
-20
-0.7% -$1.73K 0.03% 584
2019
Q2 		$226K Sell
2,742
-140
-5% -$11K 0.02% 618
2019
Q1 		$233K Buy
2,882
+825
+40% +$65K 0.06% 319
2018
Q4 		$156K Sell
2,057
-73
-3% -$5.7K 0.03% 456
2018
Q3 		$169K Buy
+2,130
New +$161K 0.08% 235
2017
Q4 		– Sell
-1,637
Closed -$113K – 350
2017
Q3 		$113K Sell
1,637
-1,595
-49% -$101K 0.03% 448
2017
Q2 		$220K Buy
3,232
+58
+2% +$3.79K 0.05% 330
2017
Q1 		$192K Sell
3,174
-935
-23% -$54.4K 0.05% 319
2016
Q4 		$224K Sell
4,109
-2,975
-42% -$169K 0.04% 442
2016
Q3 		$466K Buy
7,084
+3,931
+125% +$257K 0.08% 259
2016
Q2 		$190K Buy
3,153
+255
+9% +$14.8K 0.06% 310
2016
Q1 		$163K Buy
2,898
+994
+52% +$59.7K 0.06% 325
2015
Q4 		$129K Buy
1,904
+50
+3% +$3.28K 0.05% 353
2015
Q3 		$117K Buy
1,854
+457
+33% +$30.1K 0.04% 391
2015
Q2 		$89K Sell
1,397
-3
-0.2% -$205 0.03% 502
2015
Q1 		$95K Sell
1,400
-35
-2% -$2.43K 0.03% 478
2014
Q4 		$101K Sell
1,435
-1,020
-42% -$73K 0.03% 446
2014
Q3 		$175K Buy
2,455
+550
+29% +$40.3K 0.03% 488
2014
Q2 		$130K Buy
+1,905
New +$138K 0.07% 203

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Next Financial Group's AZN Position: Q4 2021 in Review

Next Financial Group increased its AstraZeneca (AZN) stake by 90% in Q4 2021, buying an estimated $52K and bringing the position to 932 shares worth $109K. The position accounts for 0.01% of the portfolio, ranked #1118.

Next Financial Group first reported a position in AZN in Q2 2014 and has held it in 27 quarters since. The position peaked at $466K in Q3 2016. 949 funds tracked by Wall St. Rank hold AZN as of Q4 2021.

  • Next Financial Group held 932 shares of AstraZeneca worth $109K as of Q4 2021.
  • Next Financial Group bought 442 AstraZeneca shares in Q4 2021, an estimated $52K.
  • AstraZeneca made up 0.01% of Next Financial Group's portfolio in Q4 2021, its #1118 holding.
  • Next Financial Group first reported a position in AstraZeneca in Q2 2014 and has held it in 27 quarters since.
  • Next Financial Group's AstraZeneca position peaked at $466K in Q3 2016.
  • 949 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.